{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:56:50Z","timestamp":1773035810386,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY035312"],"award-info":[{"award-number":["R01EY035312"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015112","name":"Melza M. and Frank Theodore Barr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajoc.2026.102533","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:48:05Z","timestamp":1769672885000},"page":"102533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Netarsudil-associated conjunctival fragility"],"prefix":"10.1016","volume":"41","author":[{"given":"Hursuong","family":"Vongsachang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emory","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Q.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-4168","authenticated-orcid":false,"given":"Milica A.","family":"Margeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajoc.2026.102533_bib1","first-page":"205","article-title":"Pharmaceutical approval update","volume":"43","author":"Choy","year":"2018","journal-title":"P T Peer-Rev J Formul Manag"},{"key":"10.1016\/j.ajoc.2026.102533_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102533_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho Kinase Elevated IOP Treatment Trial (ROCKET-2)","volume":"200","author":"Kahook","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102533_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/DDDT.S435522","article-title":"The role of rho kinase inhibitors in corneal diseases","volume":"18","author":"Futterknecht","year":"2024","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.ajoc.2026.102533_bib5","article-title":"Crystalline keratopathy following long-term netarsudil therapy","volume":"35","author":"Cummings","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2026.102533_bib6","article-title":"Netarsudil-associated conjunctival pigmentation","volume":"38","author":"Azargui","year":"2025","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2026.102533_bib7","article-title":"Netarsudil-associated reticular corneal epithelial edema","volume":"25","author":"Tran","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102533_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/IJG.0000000000001698","article-title":"Netarsudil-related eyelid wound dehiscence","volume":"30","author":"Kim","year":"2021","journal-title":"J Glaucoma"},{"issue":"11","key":"10.1016\/j.ajoc.2026.102533_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/IJG.0000000000002124","article-title":"Partial stenosis and complete punctal closure following topical netarsudil use for Glaucoma","volume":"31","author":"Rashad","year":"2022","journal-title":"J Glaucoma"},{"issue":"18","key":"10.1016\/j.ajoc.2026.102533_bib10","first-page":"3418","article-title":"Ocular effects of Rho kinase (ROCK) inhibition: a systematic review","volume":"38","author":"Lin","year":"2024","journal-title":"Eye Lond Engl"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102533_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/IJG.0000000000001956","article-title":"Anterior subcapsular cataract formation with long-term topical netarsudil treatment for glaucoma","volume":"31","author":"Chang","year":"2022","journal-title":"J Glaucoma"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102533_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ophtha.2025.02.020","article-title":"Early postoperative conjunctival complications leading to exposure of surgically implanted CorNeat EverPatch devices","volume":"132","author":"Kanter","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2026.102533_bib13","series-title":"StatPearls","article-title":"Netarsudil ophthalmic solution","author":"Patel","year":"2024"},{"key":"10.1016\/j.ajoc.2026.102533_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtos.2024.02.003","article-title":"Immunologic basis for development of keratoconjunctivitis sicca in systemic autoimmune diseases: role of innate immune sensors","volume":"32","author":"Stern","year":"2024","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102533_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3382","article-title":"An in vitro study of scarring formation mediated by human Tenon fibroblasts: effect of Y-27632, a Rho kinase inhibitor","volume":"37","author":"Ibrahim","year":"2019","journal-title":"Cell Biochem Funct"},{"issue":"12","key":"10.1016\/j.ajoc.2026.102533_bib16","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1167\/iovs.07-0878","article-title":"Potential role of rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery","volume":"48","author":"Honjo","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2026.102533_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exer.2016.07.001","article-title":"The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts","volume":"149","author":"Futakuchi","year":"2016","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.ajoc.2026.102533_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/02713683.2023.2217367","article-title":"Effects of Ripasudil, a rho-kinase inhibitor, on scar formation in a mouse model of filtration surgery","volume":"48","author":"Ko","year":"2023","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajoc.2026.102533_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/bs.pbr.2015.04.014","article-title":"Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery","volume":"220","author":"Van de Velde","year":"2015","journal-title":"Prog Brain Res"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102533_bib20","article-title":"Rho-kinase pathway inhibition for proliferative vitreoretinopathy: assessing the therapeutic potential of netarsudil","volume":"65","author":"Sanchez-Suarez","year":"2024","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajoc.2026.102533_bib21","article-title":"Effect of Rho-kinase inhibition on a patient-derived model of proliferative vitreoretinopathy","volume":"62","author":"Ramos","year":"2021","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajoc.2026.102533_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cells14040258","article-title":"Drug- and cell-type-specific effects of ROCK inhibitors as a potential cause of reticular corneal epithelial edema","volume":"14","author":"Schl\u00f6tzer-Schrehardt","year":"2025","journal-title":"Cells"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:58:43Z","timestamp":1773032323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993626000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"alternative-id":["S2451993626000216"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102533","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Netarsudil-associated conjunctival fragility","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102533"}}